We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking ARWR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AR

Arrowhead Pharmaceuticals, Inc. (ARWR) short interest & options flow

NASDAQ

Arrowhead Pharmaceuticals reports fiscal first-quarter results today against a bruising backdrop: the stock has dropped 20% over the past week and 21% over the past month, closing at $49.36 on Wednesday, less than half the Street's mean price target of $107.71. Short interest has built steadily into the print. Bears now hold roughly 8.6% of the free float, up 22% over the past…

Latest pulse27 Jul 2026

ARWR short interest surged 20.3% in one day to 7.0% of float, driven by a sharp spike in borrowed shares despite ample availability at 2,283%.

$49.36+0.73% 1d-19.94% 1w-21.34% 1mClose: 11 Nov 2026
Cost to borrow
Low and dropping
Live CTB on ORTEX →
Availability
High
Live availability on ORTEX →
Market cap
$6.97B
Next earnings
12 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Arrowhead Pharmaceuticals, Inc. (ARWR) share price and short interest (% of free float), six months to November 11, 2026

ARWR news and analysis

RSS

No long-form analysis yet for ARWR. Pulse alerts and the live data picture are available on ORTEX.

Open ARWR on ORTEX →

Want the live picture for ARWR?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ARWR — free to start on ORTEX.

Sign up for free →Open ARWR on ORTEX